Geispolsheim, France

Françoise Richard-Tiberghien

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Françoise Richard-Tiberghien: Innovator in Pharmaceutical Chemistry

Introduction

Françoise Richard-Tiberghien is a notable inventor based in Geispolsheim, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work has implications for treating various diseases, showcasing the importance of research and development in healthcare.

Latest Patents

Françoise Richard-Tiberghien holds a patent for an L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid. This patent includes various forms of the compound and outlines its potential applications in pharmaceutical and veterinary compositions. The invention aims to provide effective treatments for a range of diseases, highlighting the innovative nature of his work.

Career Highlights

Richard-Tiberghien is associated with Enyo Pharma, a company dedicated to advancing therapeutic solutions. His role at the company has allowed him to focus on the development of novel compounds that can significantly impact patient care. His expertise in pharmaceutical chemistry has been instrumental in driving the company's research initiatives forward.

Collaborations

Throughout his career, Françoise Richard-Tiberghien has collaborated with esteemed colleagues such as Raphaël Darteil and Jacky Vonderscher. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical field.

Conclusion

Françoise Richard-Tiberghien's contributions to pharmaceutical chemistry exemplify the vital role of inventors in advancing medical science. His patent for an L-lysine salt compound demonstrates his commitment to developing effective treatments for various diseases. Through his work at Enyo Pharma and collaborations with fellow researchers, he continues to make a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…